4//SEC Filing
Shah Prem S 4
Accession 0001127602-24-005449
CIK 0000064803other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:46 PM ET
Size
18.1 KB
Accession
0001127602-24-005449
Insider Transaction Report
Form 4
Shah Prem S
EVP and Group President
Transactions
- Sale
Common Stock
2024-02-16$76.95/sh−29,473$2,267,947→ 39,764.762 total
Holdings
- 33,754.62
Phantom Stock Credits
Exercise: $1.00→ Common Stock (33,754.62 underlying) - 26,580
Stock Option
Exercise: $75.24From: 2021-08-31Exp: 2028-08-31→ Common Stock (26,580 underlying) - 89,073
Stock Option
Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (89,073 underlying) - 846
Stock Option
Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (846 underlying) - 41,580
Stock Option
Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (41,580 underlying) - 29,649
Common Stock (Restricted)
- 28,596
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (28,596 underlying) - 28,723
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (28,723 underlying) - 4,788.942
ESOP Common Stock
- 3,350.356
Stock Unit (deferred)
- 9,469
Stock Option
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (9,469 underlying)
Footnotes (11)
- [F1]Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between 76.93 to 76.99 per share.
- [F10]Option became exercisable in four equal installments, commencing 4/1/2023.
- [F11]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
- [F2]Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
- [F3]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- [F4]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- [F5]Option became exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
- [F6]Option became exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised
- [F7]Option became exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
- [F8]Option became exercisable in three equal installments, commencing on 8/31/2021.
- [F9]Option became exercisable in three equal installments commencing 04/01/2022.
Documents
Issuer
CVS HEALTH Corp
CIK 0000064803
Entity typeother
Related Parties
1- filerCIK 0001900910
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 6:46 PM ET
- Size
- 18.1 KB